These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 8989951)

  • 1. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE; Kamerer DB
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
    Atlas JT; Parnes LS
    Am J Otol; 1999 May; 20(3):357-63. PubMed ID: 10337978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK; Sandooram D; Prinsley PR
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
    Corsten M; Marsan J; Schramm D; Robichaud J
    J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic gentamicin in Ménière's disease: results of therapy.
    Murofushi T; Halmagyi GM; Yavor RA
    Am J Otol; 1997 Jan; 18(1):52-7. PubMed ID: 8989952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
    Crane BT; Minor LB; Della Santina CC; Carey JP
    Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
    Kaplan DM; Nedzelski JM; Chen JM; Shipp DB
    Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L; Stokroos R; Kingma H
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.